Table 3

 Published series about outcome of myocarditis in the paediatric age group

StudyType of myocarditisNo of patientsClinical dataViral docEMBAge (years)IA drugsDeath or TxLVF rec/surv
*Median age; †mean (SD) age.
AFM, acute fulminant myocarditis; AM, acute myocarditis; doc, documentation (titres or cultures); EMB, endomyocardial biopsy evidence of myocarditis; IA, immunoactive (corticosteroids, azathioprine, ciclosporin and intravenous polyclonal immunoglobulin); LVF, left ventricular function; NA, not available; rec, recovery; surv, survivors without heart transplantation; Tx, heart transplantation.
Matitiau9AM + AFM9YesYes100%0.6*Yes (n = 4)25/7
Lee5AM + AFM35YesYes100%3.3*Yes627/29
Kleinert10AM9NoNo100%2.1†Yes09/9
Gagliardi7AM20NoNo100%1.9†Yes010/20
Duncan6AFM15YesYes50%4.6*Yes87/7
Stiller19AFM4YesYes100%4†No13/4
Calabrese11AM28YesYes100%4*NA92/19
Ahdoot12AFM5YesNo80%10*Yes13/4
English21AFM + AM41YesYes85%2.2*Yes1027/31